SEC EDGAR published this disclosure on 2026-08-10. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001591467-26-000004
acquired disposedD
codeM
direct or indirectD
form4
is derivativetrue
issuer nameAkebia Therapeutics, Inc.
labelExercise of derivative
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001591467-26-000004",
"acquired_disposed": "D",
"code": "M",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": true,
"issuer_name": "Akebia Therapeutics, Inc.",
"label": "Exercise of derivative",
"person_name": "Butler John P.",
"price": 0,
"role": "Director, CEO and President",
"security": "Stock Option (Right to buy)",
"shares": 350000,
"shares_owned_after": 525000,
"source_path": "edgar/data/1517022/0001591467-26-000004.txt",
"ticker": "AKBA",
"transaction_date": "2026-08-06",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.